SN-38 (or 5-FU) drug encapsulation in Iiposomes transported by magnetotactic bacteria for localizedcolorectal cancer treatment
Cancers are treated today with the appropriate combination of chemotherapy drugs, surgery
and radiation. Chemotherapy is almost invariably dosed intravenously, and enters the
systemic blood flow where it circulates around the whole body, coming into contact with
healthy cells as well as cancerous ones. This systemic dosing has two big problems: too little
drug gets to cancer cells, and too much drug comes into contact with healthy cells, causing
side effects. Frequently, these dose-limiting side-effects prevent us from delivering the
maximally effective anti-cancer drug dose.
Professor Sylvain Martel of Ecole Polytechnique de Montreal’s Nanorobotics laboratory has
pioneered an approach using special bacteria that can be directed by a magnE)tic field to
deliver chemotherapy directly to the site of tumors, reducing side-effects. With the support of
a team of co-investigators from McGill University (Drs. Te Vuong, Gerald Balisl, Maryam
Tabrizian, Nicole Beauchemin, Danuta Radzioch) and the Universite de Montreal (Dr. Louis
Gaboury),
View Full Project DescriptionSylvain Martel;Danuta Radzioch;Michel Lafleur;Maryam Tabrizian
Quebec Consortium for Drug Discovery (Quebec, QC);Syzent Partners
Engineering
Manufacturing
École Polytechnique de Montréal; McGill University; Université de Montréal
Accelerate